Biotech specialized in precision medicine, our mission is to bring innovative therapeutic and diagnostic solutions to treat resistant and metastasis cancer.. .
Perfetto, il tuo title contiene tra 10 e 70 caratteri.
Grande, la tua meta description contiene tra 70 e 160 caratteri.
Abbiamo trovato 12 immagini in questa pagina web. 2 attributi alt sono vuoti o mancanti. Aggiungi testo alternativo in modo tale che i motori di ricerca possano comprendere meglio il contenuto delle tue immagini.
Buono, il rapporto testo/codice HTML di questa pagina e maggiore di 15, e minore di 25 percento.
Perfetto, non e stato rilevato contenuto Flash in questa pagina.
Grande, non sono stati rilevati Iframes in questa pagina.
| locale | en_GB |
|---|---|
| locale:alternate | fr_FR |
| type | website |
| title | Oncodesign Precision Medicine |
| description | Biotech specialized in precision medicine, our mission is to bring innovative therapeutic and diagnostic solutions to treat resistant and metastasis cancer. |
| url | http://www.oncodesign.com/ |
| site_name | Oncodesign Precision Medicine |
| image | https://www.oncodesign.com/wp-content/uploads/2022/09/oncodesign-pm-home-intro.png |
| image:width | 599 |
| image:height | 493 |
| image:type | image/png |
Internal Links 95.83%
External Links [Passing Juice 4.17%]
External Links [noFollow 0%]
| Anchor | Link | Type | Juice |
|---|---|---|---|
| Learn more | https://oncodesign-services.com/ | Externo | Passing Juice |
| Our pipeline | https://oncodesign.com/our-pipeline/ | Interno | Passing Juice |
| Partnering | https://oncodesign.com/our-pipeline/partnering/ | Interno | Passing Juice |
| Our innovation technologies | https://oncodesign.com/our-innovation-technologies/ | Interno | Passing Juice |
| OncoSNIPER | https://oncodesign.com/our-innovation-technologies/oncosniper/ | Interno | Passing Juice |
| Nanocyclix | https://oncodesign.com/our-innovation-technologies/nanocyclix/ | Interno | Passing Juice |
| PROMETHE | https://oncodesign.com/our-innovation-technologies/theranostics/ | Interno | Passing Juice |
| Investors | https://oncodesign.com/investors/ | Interno | Passing Juice |
| Message from the chairman | https://oncodesign.com/investors/message-from-the-chairman/ | Interno | Passing Juice |
| Regulated information [FR] | https://oncodesign.com/investors/regulated-information/ | Interno | Passing Juice |
| Press Release | https://oncodesign.com/press-release/ | Interno | Passing Juice |
| General Meetings [FR] | https://oncodesign.com/fr/investisseurs/assemblee-generale/ | Interno | Passing Juice |
| About us | https://oncodesign.com/about-us/ | Interno | Passing Juice |
| Latest news | https://oncodesign.com/about-us/news/ | Interno | Passing Juice |
| Our history | https://oncodesign.com/about-us/our-history/ | Interno | Passing Juice |
| Management | https://oncodesign.com/fr/a-propos/management-2/ | Interno | Passing Juice |
| Our HR policy | https://oncodesign.com/about-us/careers/ | Interno | Passing Juice |
| Our CSR approach | https://oncodesign.com/about-us/our-csr-approach/ | Interno | Passing Juice |
| FederAidd | https://oncodesign.com/about-us/federaidd/ | Interno | Passing Juice |
| Contact us | https://oncodesign.com/contact-us/ | Interno | Passing Juice |
| OPM announces a 6 million euros bank financing | https://oncodesign.com/opm-announces-a-6-million-euros-bank-financing/ | Interno | Passing Juice |
| OPM announces positive interim results of its Phase 1 study | https://oncodesign.com/opm-announces-positive-interim-results-of-its-phas | Interno | Passing Juice |
| Legal notice | https://oncodesign.com/legal-notice/ | Interno | Passing Juice |
| Personal data policy | https://oncodesign.com/personal-data-policy/ | Interno | Passing Juice |
| Keyword | Contenuto | Title | Keywords | Description | Headings |
|---|---|---|---|---|---|
| news | 5 |  |
|
|
 |
| therapeutic | 5 | |
|
|
|
| opm | 4 | |
|
|
|
| learn | 4 | |
|
|
|
| more | 4 | |
|
|
|
| innovative | 3 | |
|
|
|
| pipeline | 3 | |
|
|
|
| read | 3 | |
|
|
|
| innovation | 3 | |
|
|
|
| technologies | 3 | |
|
|
|
| oncodesign | 3 | |
|
|
|
| investors | 3 | |
|
|
|
14 Lunghezza
Perfetto. Hai dichiarato che il tuo charset e UTF-8.
Buono. La tua lingua dichiarata EN. 
Grande! Non abbiamo trovato tags HTML deprecati nel tuo codice.
Grande, il tuo sito usa una favicon.
Grande. Nessun indirizzo mail e stato trovato in plain text!
Questa pagina non sfrutta i vantaggi di Dublin Core.
Non abbiamo riscontrato codice CSS Print-Friendly.
oncodesign precision medicine, newsletter, attention javascript est désactivé sur votre poste. ce site nécessite l'activation de javascript pour fonctionner correctement., our science, news, to find the best therapeutic path, our pipeline, our technologies, opm announces a 6 million euros bank financing, opm announces positive interim results of its phase 1 study, goals, opm, medicine, all, services, covering, dedicated, discovery, model, areas, javascript, innovative, patients, attention, announces, solutions, first--class, benefit, latest, newsletter, precision, programs, therapeutic, technologies, shared, oncodesign, october, opportunities, learn, pipeline, read, activities, best--class, promethe, investors, news, drug, oncosniper, technological, highly, innovation, science, also, more, explore, policy, patient, nanocyclix, cro, several, oncodesign.com.
